iSpecimen Inc. has announced that it received a notification from the Nasdaq Stock Market LLC on June 4, 2025, indicating non-compliance with the Nasdaq Listing Rule 5550(b)(1), which mandates a minimum of $2.5 million in stockholders' equity for continued listing on the Nasdaq Capital Market. As of March 31, 2025, the company's stockholders' equity stood at $1,668,513. While this notification does not immediately affect the trading of iSpecimen's common stock under the symbol "ISPC," the company now has 45 days to submit a compliance plan to Nasdaq. If the plan is accepted, iSpecimen may be given up to 180 days to achieve compliance. The company plans to submit a compliance plan within the required timeframe, but there is no assurance that the plan will be accepted or that compliance will be regained. If the plan is rejected, iSpecimen can appeal the decision to a Nasdaq Hearings Panel.